Judith Bruchfeld - Infectious Diseases

Author Information

Judith Bruchfeld is affiliated with the Division of Infectious Diseases at the Department of Medicine, Solna, Karolinska Institute, and the Department of Infectious Diseases at Karolinska University Hospital in Stockholm, Sweden. Her work primarily focuses on infectious diseases, with a particular interest in tuberculosis and its various aspects.

Research Contributions

Judith Bruchfeld has made significant contributions to the field of infectious diseases, with a strong emphasis on tuberculosis research. Her work includes studies on active and latent tuberculosis, drug resistance, immune response to tuberculosis, and the impact of tuberculosis screening programs. Additionally, she has also contributed to research on COVID-19, particularly on post-COVID-19 symptoms and follow-up in different patient settings.

Aliases

Judith Bruchfeld is also known by the aliases J Bruchfeld and J. Bruchfeld in academic and research publications.

Publication and Citation Metrics

Metric	Value
Total Citations	4355
h-index	31
Total Papers	118

Publications:

A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis

DOI: 10.1101/2022.04.22.22274170

Year: 2022

Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics

DOI: 10.3899/jrheum.201251

Year: 2021

Extrapulmonary Tuberculosis

DOI: 10.1007/978-3-030-66703-0_29

Year: 2021

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China

DOI: 10.1183/13993003.01925-2021

Year: 2021

Long-Haul Post–COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome

DOI: 10.1016/j.jaccas.2021.01.009

Year: 2021

High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids

DOI: 10.3389/fimmu.2021.727300

Year: 2021

The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting

DOI: 10.1128/JCM.01370-21

Year: 2021

Late Breaking Abstract - Early follow-up of hospitalised and non-hospitalised patients with Covid-19 in a Swedish setting

DOI: 10.1183/13993003.congress-2021.pa487

Year: 2021

Stimulation with mycobacterial glycolipids and PPD reveals different innate immune response profiles in active and latent TB

DOI: 10.1101/2021.04.04.434373

Year: 2021

Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region

DOI: 10.1007/s10198-021-01265-5

Year: 2021

What is the Role of Healthcare Providers in Managing Infectious Diseases in Pregnancy?

How Does Direct Contact Transmission Occur?

How Does the NIH Contribute to Infectious Disease Research?

What Are Some Common Vaccines?

What is a Cohort in Infectious Diseases?

Why is Respiratory Hygiene Important?

Can Colonization Lead to Infection?

How Can Adverse Effects be Minimized?

How Does the CDC Respond to Infectious Disease Outbreaks?

What Are the Challenges in Genomic Studies of Infectious Diseases?

Partnered Content Networks

Relevant Topics